This strategic appointment marks a significant milestone in Cellevate’s mission to expand its U.S. footprint and commercialize cutting-edge solutions to the biomanufacturing industry, it states.

Jennifer Valdes

Jennifer Valdes has over 15 years experience executing effective sales strategies in the biopharmaceutical manufacturing arena, leveraging a hands-on approach to foster customer relationships and drive revenue growth. With a technical background in molecular microbiology, she has held various regional and global strategic sales positions at Sartorius, and most recently served as OEM Sales Manager for Western US at SaniSure. 

Jennifer Valdes holds a Master of Science in Cell and Molecular Biology.

“I’m incredibly excited to join Cellevate at such a key time, as we are bringing Cellevat3d nanofiber-based cell culture systems to the U.S. market,” says Jennifer Valdes, VP Sales & Marketing US of Cellevate. “This innovative technology provides the solution to many of the challenges in upstream bioprocessing, especially for cell and gene therapy, and I look forward to working closely with our leadership teams to achieve the milestones that will fuel our expansion and success.”